Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer

Despite a good initial response to front-line chemotherapy, majority of the ovarian cancer patients relapse with consecutive phases of recurrences; and nearly 60% die within 5 years due to the development of a chemoresistant disease. This study investigated whether inhibition of the Janus kinase 2 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Emily, Luwor, Rodney, Burns, Christopher, Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908273/
https://www.ncbi.nlm.nih.gov/pubmed/29682172
http://dx.doi.org/10.18632/oncotarget.24615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908273/
https://www.ncbi.nlm.nih.gov/pubmed/29682172
http://dx.doi.org/10.18632/oncotarget.24615

Ejemplares similares